Similar Articles
191 Multidisciplinary approaches in the management of advanced hepatocellular carcinoma: Exploring future directions
192 Intratumoural microorganism can affect the progression of hepatocellular carcinoma
193 Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma
194 Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy
195 Conversion therapy for hepatocellular carcinoma to improve treatment strategies for intermediate and advanced stages
196 Liver transplantation following two conversions in a patient with huge hepatocellular carcinoma and portal vein invasion: A case report
197 Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model
198 Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in patients with hepatocellular carcinoma and portal vein tumor thrombus
199 Establishment and evaluation of prediction model of recurrence after laparoscopic choledocholithotomy
200 Combined transarterial chemoembolization and tislelizumab for patients with unresectable hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA